Chronic Hand Eczema: Addressing Barriers to Care Through Treatment Advancements, October 2024 (Vol. 45. Supp. 08)

home / journals / dermatology-times / chronic-hand-eczema-addressing-barriers-to-care-through-treatment-advancements

Click here to download the digital interactive supplement.

Delgocitinib Reduces Inflammation and Restores Skin Barrier in CHE as a Topical Pan-JAK Inhibitor

Kaitlyn Bader, Assistant Managing Editor

December 3rd 2024

Treatment with delgocitinib led to a significant decrease in the expression of inflammatory markers that were elevated in severe cases compared with mild cases at baseline.

Chronic Hand Eczema: November 2024 Supplement Recap

Marie Bosslett, Assistant Editor

November 29th 2024

Article

Learn more about the in-depth topics covered in the November 2024 CHE digital supplement of Dermatology Times.

Test Your Knowledge: Chronic Hand Eczema

Maddi Hebebrand, MC, Associate Editor;Matthew Zirwas, MD

November 1st 2024

Article

Click here to test your knowledge and read more about the treatment landscape of chronic hand eczema.

Journal Digest: October 25

Marie Bosslett, Assistant Editor

October 25th 2024

Article

This review of the latest dermatologic studies includes discussions on the development of the Hand Eczema Impact Scale, the role of tofacitinib on Th1 and Th2 cytokines, and more.